Patient knowledge and perceptions of atrial fibrillation and anticoagulant therapy: Effects of an educational intervention programme: The West Birmingham Atrial Fibrillation Project

https://doi.org/10.1016/j.ijcard.2005.07.031Get rights and content

Abstract

Objective

Previous research has demonstrated that patients with atrial fibrillation (AF) possess very little knowledge of their disease, the consequences of AF and the benefits/risks of anti-coagulant therapy. The aim of this pilot study was to examine patient's knowledge and perceptions of AF and their anticoagulant treatment before and after a brief educational intervention.

Materials and methods

Ninety-three patients (47 male; mean (S.D.) age 67.3 (11.6) years) completed the baseline interview to assess their knowledge and perceptions of AF. All patients were given an information booklet which explained what AF was, associated symptoms, the possible causes and consequences of AF, treatment options and their benefits/risks, what the INR is and what factors may effect it. The booklet was explained to each patient by the researcher and given to the patient to take away for reference. Thirty-three (35.5%) patients (12 men; mean (S.D.) age 68.0 (13.6) years) completed the follow-up assessment to re-assess their knowledge and perceptions of AF.

Results

Only 49% of patients could name their cardiac condition at baseline, although the majority were aware that AF was an arrhythmia (80% baseline vs. 91% follow-up). Only about half the patients perceived AF as a serious condition or were aware that AF predisposes to thromboembolism at baseline. Following the educational intervention there was a non-significant increase in patient knowledge of the risks associated with AF. Of those who completed both questionnaires, 52% were aware that anticoagulants prevented blood clots, which increased to 70% post-intervention. However, few patients were aware of the benefit of stroke prevention associated with anticoagulants at baseline (21%) or after the educational intervention (27%). The intervention had little effect on increasing awareness of the bleeding risks associated with anticoagulants, although three in five people appeared to appreciate these risks. However, the educational intervention significantly improved patient's knowledge of the target INR range and factors that may affect INR levels (p = 0.001 and p = 0.014, respectively) for those who completed both questionnaires.

Conclusions

Most patients with AF possess very limited knowledge about their cardiac condition, its consequences, and how anticoagulant treatment can benefit them. This pilot study has demonstrated that a brief educational intervention with an information booklet can help to somewhat improve their knowledge about anticoagulation therapy for AF.

Introduction

Despite the overwhelming evidence from clinical trials that thromboprophylaxis with warfarin reduces the incidence of stroke and mortality, such therapy remains under-utilised [1], [2], [3]. Patients' beliefs about their healthcare are important factors that influence their decision to accept, decline, or comply with anticoagulant therapy, particularly warfarin [4], [5]. Patients need to understand the importance of attending for regular blood tests, to maintain the INR at an optimal level to prevent bleeding or a stroke, and the interactions of warfarin with antibiotics, alcohol, and foods rich in vitamin K [1], [6]. However, previous studies have demonstrated that many patients with AF possess very little knowledge of their disease [7], [8] and do not understand the risks and/or benefits of anticoagulant therapy [7], [8], [9], [10].

The paucity in patient's knowledge concerning AF could be attributed to the lack of information and explanations given by healthcare professionals due to the time constraints of outpatient clinics, the lack of appropriate educational literature, and the risk/benefit analogies employed by physicians [9]. Evidence suggests that compliance is improved if patients know what they have been prescribed, the reasons for taking it, what will happen if they fail to adhere as prescribed, any factors which may alter drug efficacy, and any possible side effects [11]. Patient education about the consequences of untreated disease and the importance of adhering to the medication regimen is vital to ensure compliance and disease management [11], [12]. Certainly, educational interventions in other chronic diseases, such as diabetes [13], ulcerative colitis [14], heart failure [15], and epilepsy [16] have demonstrated significant improvements in knowledge [13], [14], symptom monitoring [15], disease management [13], [14], [15], and medication compliance [15], [16].

Despite our previous work examining patient's knowledge of the disease and its treatment [7], [8], we are unaware of any study to date which has examined the effect of an educational intervention in AF patients. The aim of this pilot study was to extend our previous work [7], [8] by examining patient's knowledge and perceptions of AF and their anticoagulant treatment, before and after a brief educational intervention, utilising a specifically designed information booklet on AF.

Section snippets

Materials and methods

Consecutive patients with a documented diagnosis of atrial fibrillation (≥ 3 months ago), currently or previously on warfarin, attending the AF outpatient clinic at the City Hospital, Birmingham, between October 2003 and February 2004, were eligible for inclusion. Socio-demographic and clinical data was recorded from patients' hospital records. The Local Research Ethics Committee approved the study and all participants provided written informed consent.

A standardised questionnaire was devised

Results

Ninety-eight patients were approached over the study period, but five declined participation; reasons given were inability to speak English (n = 1) or return to complete the follow-up questionnaire (n = 4). The study cohort comprised 93 (94.5%) patients (47 men; mean (S.D.) age 67.3 (11.6) years; 89 (95.7%) White Europeans) (see Table 1). The median (IQR) duration of documented AF was 24.0 (15.0–48.0) months. The majority (72%) were currently taking warfarin. Thirty-three (35.5%) patients (12 men;

Discussion

Understanding the nature and consequences of AF and anticoagulant therapy are essential to optimise the management of AF and allow the patient to participate in maintaining their health, in consultation with health professionals. The present study revealed that fewer than half of the patients were able to name their heart condition; considerably less than reported in an earlier study of AF patients [8]. However, in the present study, the majority of patients were aware that AF was a

Acknowledgements

We acknowledge the support of the Sandwell and West Birmingham Hospitals NHS Trust Research and Development programme for the Haemostasis Thrombosis and Vascular Biology Unit. This project is partly funded by an educational non-promotional research project grant from Astra Zeneca, Charnwood, UK, but is a totally independent study.

References (17)

  • D.G. Bruce et al.

    Diabetes education and knowledge in patients with type 2 diabetes from the community: the Freemantle diabetes study

    J Diabetes Complications

    (2003)
  • L. Liu et al.

    Medication education for patients with epilepsy in Taiwan

    Seizure

    (2003)
  • T. Bungard et al.

    Why do patients with atrial fibrillation not receive warfarin?

    Arch Intern Med

    (2000)
  • R.S. Stafford et al.

    Recent national patterns of warfarin use in atrial fibrillation

    Circulation

    (1998)
  • G. Mendelson et al.

    Under-utilization of warfarin in older persons with chronic nonvalvular atrial fibrillation at high risk for developing stroke

    J Am Geriatr Soc

    (1998)
  • A. Howitt et al.

    Implementing evidence-based medicine in general practice: audit and qualitative study of antithrombotic treatment for atrial fibrillation

    BMJ

    (1999)
  • J. Protheroe et al.

    The impact of patients' preferences on the treatment of atrial fibrillation: observational study of patient-based decision analysis

    BMJ

    (2000)
  • G.Y.H. Lip et al.

    ABC of antithrombotic therapy: antithrombotic therapy for atrial fibrillation

    BMJ

    (2002)
There are more references available in the full text version of this article.

Cited by (146)

View all citing articles on Scopus
View full text